• USA Home
  • PHR1761 - Nevirapine Related Compound B

EMAIL THIS PAGE TO A FRIEND
PHR1761 Sigma-Aldrich

Nevirapine Related Compound B

Pharmaceutical Secondary Standard; Certified Reference Material

Synonym: 5,11-DIHYDRO-4-METHYL- 6H-DIPYRIDO[3,2-b:2’,3’-e][1,4] DIAZEPIN-6-ONE, 5,11-Dihydro-4-methyl-6H-dipyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one

  • CAS Number 287980-84-1

  • Empirical Formula (Hill Notation) C12H10N4O

  • Molecular Weight 226.23

Purchase

Properties

Related Categories Additional Standards, Analytical Standards, Analytical/Chromatography, Chromatography, Nevirapine Impurities,
grade   certified reference material
  pharmaceutical secondary standard
packaging   pkg of 50 mg
pharmacopeia traceability   traceable to USP 1460736

Description

Analysis Note

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

General description

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards

Other Notes

This product was designed, produced and verified for accuracy and stability in accordance with ISO/IEC 17025:2005 (AClass Cert AT-1467), ISO GUIDES 34:2009 (AClass Cert AR-1470).

Footnote

To see an example of a Certificate of Analysis for this material enter LRAA8554 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

Safety & Documentation

Safety Information

Symbol 
GHS06  GHS06
Signal word 
Danger
Hazard statements 
Precautionary statements 
RIDADR 
UN 2811 6.1 / PGIII
WGK Germany 
3

Documents

Certificate of Analysis

Protocols & Articles
Related Products

Technical Service:

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Bulk Ordering & Pricing:

Need larger quantities for your development, manufacturing or research applications?